Apple Barred From Selling Watches With Blood-Oxygen Sensors in U.S., CNBC Reports
--A federal appeals court has banned Apple from selling smartwatches with blood-oxygen sensors in the U.S., CNBC reports.
--The tech giant is in an intellectual property dispute with medical-technology company Masimo over the oxygen sensor feature on its Apple Watch models.
--The U.S. International Trade Commission ruled in October that the oxygen-sensor tool violated Masimo's patents.
--Apple removed some Apple Watch models from U.S. stores for several days in December after an import ban stemming from the ruling went into effect.
Full story: https://www.cnbc.com/2024/01/17/apple-again-banned-from-selling-watches-in-us-with-blood-oxygen-sensor.html
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
January 17, 2024 15:25 ET (20:25 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth